Skip to main content
NCBI home page
Tissue Engineering and Regenerative Medicine logoLink to Tissue Engineering and Regenerative Medicine
. 2016 Apr 5;13(2):155–161. doi: 10.1007/s13770-016-9085-2

Substance P modulates properties of normal and diabetic dermal fibroblasts

Nunggum Jung 1, Jinyeong Yu 1, Jihyun Um 1, Maria Jose Dubon 1, Ki-Sook Park 2,✉
PMCID: PMC6170853  PMID: 30603395

Abstract

Dermal fibroblasts play essential roles in wound healing. However, they lose their normal regenerative functions under certain pathologic conditions such as in chronic diabetic wounds. Here, we show that substance P (SP) rescues the malfunctions of dermal fibroblasts in diabetes. SP increased the proliferation of diabetic dermal fibroblasts dose-dependently, although the effect was lower compared to the SP-stimulated proliferation of normal dermal fibroblasts. In contrast to normal dermal fibroblasts, SP increased the expression level of vascular endothelial growth factor (VEGF) and stromal cell-derived factor-1 (SDF-1) in diabetic dermal fibroblast hence, rescuing their angiogenic potential. The cellular characteristics of diabetic dermal fibroblasts modulated by SP would be able to accelerate the wound healing process through faster wound contraction and improved angiogenesis in diabetic chronic wounds. Moreover, SP pretreatment into dermal fibroblasts isolated from diabetic patients would be a promising strategy to develop autologous cell therapy for treating diabetic chronic wounds.

Key Words: Vascular endothelial growth factor, Stromal cell-derived factor-1

References

  • 1.Eming SA, Martin P, Tomic-Canic M. Wound repair and regeneration: mechanisms, signaling, and translation. Sci Transl Med 2014;6:265sr6. [DOI] [PMC free article] [PubMed]
  • 2.Werner S, Krieg T, Smola H. Keratinocyte-fibroblast interactions in wound healing. J Invest Dermatol. 2007;127:998–1008. doi: 10.1038/sj.jid.5700786. [DOI] [PubMed] [Google Scholar]
  • 3.Bainbridge P. Wound healing and the role of fibroblasts. J Wound Care. 2013;22:407–408. doi: 10.12968/jowc.2013.22.8.407. [DOI] [PubMed] [Google Scholar]
  • 4.Epstein EH, Jr, Munderloh NH. Human skin collagen. Presence of type I and type III at all levels of the dermis. J Biol Chem. 1978;253:1336–1337. [PubMed] [Google Scholar]
  • 5.Roh SS, Lee MH, Hwang YL, Song HH, Jin MH, Park SG, et al. Stimulation of the extracellular matrix production in dermal fibroblasts by velvet antler extract. Ann Dermatol. 2010;22:173–179. doi: 10.5021/ad.2010.22.2.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev. 2003;83:835–870. doi: 10.1152/physrev.2003.83.3.835. [DOI] [PubMed] [Google Scholar]
  • 7.Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature. 2008;453:314–321. doi: 10.1038/nature07039. [DOI] [PubMed] [Google Scholar]
  • 8.Dubon MJ, Park KS. Substance P enhances the proliferation and migration potential of murine bone marrow-derived mesenchymal stem celllike cell lines. Exp Ther Med. 2015;9:1185–1191. doi: 10.3892/etm.2015.2291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Hong HS, Lee J, Lee E, Kwon YS, Lee E, Ahn W, et al. A new role of substance P as an injury-inducible messenger for mobilization of CD29(+) stromal-like cells. Nat Med. 2009;15:425–435. doi: 10.1038/nm.1909. [DOI] [PubMed] [Google Scholar]
  • 10.Kant V, Gopal A, Kumar D, Bag S, Kurade NP, Kumar A, et al. Topically applied substance P enhanced healing of open excision wound in rats. Eur J Pharmacol. 2013;715:345–353. doi: 10.1016/j.ejphar.2013.04.042. [DOI] [PubMed] [Google Scholar]
  • 11.Leal EC, Carvalho E, Tellechea A, Kafanas A, Tecilazich F, Kearney C, et al. Substance P promotes wound healing in diabetes by modulating inflammation and macrophage phenotype. Am J Pathol. 2015;185:1638–1648. doi: 10.1016/j.ajpath.2015.02.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Yang L, Di G, Qi X, Qu M, Wang Y, Duan H, et al. Substance P promotes diabetic corneal epithelial wound healing through molecular mechanisms mediated via the neurokinin-1 receptor. Diabetes. 2014;63:4262–4274. doi: 10.2337/db14-0163. [DOI] [PubMed] [Google Scholar]
  • 13.Kim HJ, Song SB, Choi JM, Kim KM, Cho BK, Cho DH, et al. IL-18 downregulates collagen production in human dermal fibroblasts via the ERK pathway. J Invest Dermatol. 2010;130:706–715. doi: 10.1038/jid.2009.302. [DOI] [PubMed] [Google Scholar]
  • 14.Sorrell JM, Caplan AI. Fibroblast heterogeneity: more than skin deep. J Cell Sci. 2004;117:667–675. doi: 10.1242/jcs.01005. [DOI] [PubMed] [Google Scholar]
  • 15.Robins SP, Milne G, Duncan A, Davies C, Butt R, Greiling D, et al. Increased skin collagen extractability and proportions of collagen type III are not normalized after 6 months healing of human excisional wounds. J Invest Dermatol. 2003;121:267–272. doi: 10.1046/j.1523-1747.2003.12373.x. [DOI] [PubMed] [Google Scholar]
  • 16.Avniel S, Arik Z, Maly A, Sagie A, Basst HB, Yahana MD, et al. Involvement of the CXCL12/CXCR4 pathway in the recovery of skin following burns. J Invest Dermatol. 2006;126:468–476. doi: 10.1038/sj.jid.5700069. [DOI] [PubMed] [Google Scholar]
  • 17.Rabbany SY, Pastore J, Yamamoto M, Miller T, Rafii S, Aras R, et al. Continuous delivery of stromal cell-derived factor-1 from alginate scaffolds accelerates wound healing. Transplant. 2010;19:399–408. doi: 10.3727/096368909X481782. [DOI] [PubMed] [Google Scholar]
  • 18.Johnson KE, Wilgus TA. Vascular endothelial growth factor and angiogenesis in the regulation of cutaneous wound repair. Wound Care (New Rochelle) 2014;3:647–661. doi: 10.1089/wound.2013.0517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Kishimoto J, Ehama R, Ge Y, Kobayashi T, Nishiyama T, Detmar M, et al. In vivo detection of human vascular endothelial growth factor promoter activity in transgenic mouse skin. Am J Pathol. 2000;157:103–110. doi: 10.1016/S0002-9440(10)64522-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Fedyk ER, Jones D, Critchley HO, Phipps RP, Blieden TM, Springer TA. Expression of stromal-derived factor-1 is decreased by IL-1 and TNF and in dermal wound healing. J Immunol. 2001;166:5749–5754. doi: 10.4049/jimmunol.166.9.5749. [DOI] [PubMed] [Google Scholar]
  • 21.Hehenberger K, Heilborn JD, Brismar K, Hansson A. Inhibited proliferation of fibroblasts derived from chronic diabetic wounds and normal dermal fibroblasts treated with high glucose is associated with increased formation of l-lactate. Wound Repair Regen. 1998;6:135–141. doi: 10.1046/j.1524-475X.1998.60207.x. [DOI] [PubMed] [Google Scholar]
  • 22.Loots MA, Lamme EN, Mekkes JR, Bos JD, Middelkoop E. Cultured fibroblasts from chronic diabetic wounds on the lower extremity (non-insulin-dependent diabetes mellitus) show disturbed proliferation. Arch Dermatol Res. 1999;291:93–99. doi: 10.1007/s004030050389. [DOI] [PubMed] [Google Scholar]
  • 23.Gale NW, Yancopoulos GD. Growth factors acting via endothelial cellspecific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev. 1999;13:1055–1066. doi: 10.1101/gad.13.9.1055. [DOI] [PubMed] [Google Scholar]
  • 24.Brown LF, Yeo KT, Berse B, Yeo TK, Senger DR, Dvorak HF, et al. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med. 1992;176:1375–1379. doi: 10.1084/jem.176.5.1375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Swift ME, Kleinman HK, DiPietro LA. Impaired wound repair and delayed angiogenesis in aged mice. Lab Invest. 1999;79:1479–1487. [PubMed] [Google Scholar]
  • 26.Corral CJ, Siddiqui A, Wu L, Farrell CL, Lyons D, Mustoe TA. Vascular endothelial growth factor is more important than basic fibroblastic growth factor during ischemic wound healing. Arch Surg. 1999;134:200–205. doi: 10.1001/archsurg.134.2.200. [DOI] [PubMed] [Google Scholar]
  • 27.Deshane J, Chen S, Caballero S, Grochot-Przeczek A, Was H L, Calzi S, et al. Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism. J Exp Med. 2007;204:605–618. doi: 10.1084/jem.20061609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Gallagher KA, Liu ZJ, Xiao M, Chen H, Goldstein LJ, Buerk DG, et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest. 2007;117:1249–1259. doi: 10.1172/JCI29710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Xu X, Zhu F, Zhang M, Zeng D, Luo D, Liu G, et al. Stromal cell-derived factor-1 enhances wound healing through recruiting bone marrow-derived mesenchymal stem cells to the wound area and promoting neovascularization. Cells Tissues Organs. 2013;197:103–113. doi: 10.1159/000342921. [DOI] [PubMed] [Google Scholar]
  • 30.Han SK, Choi KJ, Kim WK. Clinical application of fresh fibroblast allografts for the treatment of diabetic foot ulcers: a pilot study. Plast Reconstr Surg. 2004;114:1783–1789. doi: 10.1097/01.PRS.0000142415.57470.DF. [DOI] [PubMed] [Google Scholar]
  • 31.Monami M, Vivarelli M, Desideri CM, Ippolito G, Marchionni N, Mannucci E. Autologous skin fibroblast and keratinocyte grafts in the treatment of chronic foot ulcers in aging type 2 diabetic patients. J Am Podiatr Med Assoc. 2011;101:55–58. doi: 10.7547/1010055. [DOI] [PubMed] [Google Scholar]

Articles from Tissue Engineering and Regenerative Medicine are provided here courtesy of Springer

RESOURCES